Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02825264 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

STAR-LIFE Registry: STARflo Glaucoma Implant Clinical Experience Program

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 9, 2022 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. 3 versions Re-verified since Feb 11, 2021, no change to tracked fieldsv5-v7
  2. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 150 to confirmed 70
    • Study sites: 10 to 9
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Trial status: Not Yet Recruiting to Recruitingv2 Show 6 more changesShow less
    • Primary completion date: Dec 2018 to Dec 2025
    • Primary endpoint revised
    • Study completion date: Dec 2022 to Dec 2026
    • Secondary endpoints revised (3)
    • Study description expanded, about 101 words
    • Study title expanded, about 6 words
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
STARflo is a novel suprachoroidal Glaucoma Drainage Device (GDD), bleb-free, exhibiting anti-fibrotic properties. Release of this CE Marked implant has been limited to leading Glaucoma Centers in Europe.
Trial Details
NCT Number NCT02825264
Lead Sponsor iSTAR Medical
Conditions
(from sponsor)		 Open Angle Glaucoma
Related terms Glaucoma, Open-Angle
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov